Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining
Clinical trial NCT02486497 · COMPLETED
Trial details
- NCT number
- NCT02486497
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-05-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.